Patholytix is a groundbreaking solution in the realm of research and translational pathology, designed to enhance the efficiency and comfort of study management. As the first viewer that implements a study-centric approach, Patholytix simplifies the primary evaluation, peer review, and blind assessment of nonclinical toxicology studies, delivering a superior experience compared to traditional microscopy. The platform’s innovative cloud-based infrastructure facilitates seamless collaboration among remote partners, ensuring that pathologists can concurrently review studies from various locations.

Offering a range of products including the Patholytix AI Image Quality Control and Data Capture Module, the brand is equipped to accelerate drug discovery and development timelines. Their services encompass GLP-compliant digital studies, AI solutions, and scanning services designed to unlock historical pathology knowledge. Patholytix is fully scalable, allowing organizations to adapt the system to their needs effortlessly. With ISO 27001 certification, Patholytix guarantees the security of data throughout the entire workflow, empowering researchers with confidence and control over their studies.